Canine N-terminal proBNP (NT-proBNP), antibody

4CNT5

CaNT89, CaNT90, CaNT19, CaNT46, CaNT49, CaNT53

Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with:
- recombinant canine NT-proBNP with tag expressed in E. coli (CaNT90)
- recombinant canine NT-proBNP expressed in E. coli as a fusion protein with carrier (CaNT89, CaNT19 and CaNT46)
- synthetic peptides corresponding to 64-80 a.a.r. (CaNT49 and CaNT53) of canine NT-proBNP

Canine NT-proBNP and proBNP. Look the PDF file at the bottom of the page for more information.

IgG1 for MAbs CaNT89, CaNT90, CaNT19, CaNT46, CaNT49, CaNT53

Quantification of canine NT-proBNP in plasma of dogs. Recommended pairs for sandwich immunoassay (capture-detection):

CaNT90 – CaNT89
CaNT19 – CaNT89
CaNT90 – CaNT53

Extended list of two-site antibody combinations for detection of canine NT-proBNP in plasma can be provided as a supplementary material.

Protein A chromatography

PBS, pH 7.4, 0.09 % sodium azide (NaN₃)

+4 °C (+2 … +8 °C allowed)

This product is sold for research or further manufacturing use only. Standard Laboratory Practices should be followed when handling this material.

Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

These products and some applications in which these products may be used could be covered by patents issued and applicable in certain countries. As the purchase of these products does not include a license to perform any patented application, users of these products may be required to obtain a patent license depending on the specific application and country in which the product is used.